Israel's Brainsway rises on trial results of its device for quitting smoking

Brainsway

02/12/2019 15:32

** U.S.-listed shares of brain tech company  BWAY.O  rise
11.9% to $10.33 - highest in more than 2 months
    ** Company meets main and a secondary goal of a study
testing its brain stimulation technology, H4 Deep Transcranial
Magnetic Stimulation (H4 Deep TMS), help participants quit
smoking compared to placebo; no seizures were reported
 urn:newsml:reuters.com:*:nGNX6DNwCr
    ** BWAY says it intends to meet with the FDA for regulatory
submission and possible approval clearance
    ** Company's Deep TMS devices for severe depression and OCD
have already received FDA clearance 
    ** More than 59k shares traded, 10.3x BWAY's 25-day moving
avg
    ** Up to Friday's close, stock had fallen 16.8% since its
public listing in April


 (Reporting by Ruhi Soni in Bengaluru)
 ((Ruhi.Soni@thomsonreuters.com;))